Tobias Wirth

Tobias Wirth is a seasoned professional in the pharmaceutical industry, currently serving as the Commercial Director at Vayamed since April 2022, with expertise in sales, marketing, pain therapy, palliative medicine, oncology, neurology, and medical cannabinoid therapy. Prior to this role, Wirth was the Head of Field Sales at Cannamedical® Pharma GmbH, overseeing a team of 10 and managing sales responsibilities related to medicinal cannabis products. Wirth's extensive experience at Teva GmbH included various leadership positions, culminating in the role of Commercial Director, where oversight extended to multiple regional managers and a comprehensive sales and marketing portfolio. Wirth has also held positions at ProStrakan Pharma GmbH, Jenapharm GmbH & Co. KG, Berlin-Chemie AG, Sanofi-Aventis Deutschland GmbH, MSD Sharp & Dohme GmbH, Takeda Pharma Vertrieb GmbH & Co. KG, and kohlpharma GmbH, accumulating robust expertise across oncology, pain management, diabetes, and pharmaceutical sales.